Previous 10 | Next 10 |
2024-05-02 13:00:13 ET Image source: The Motley Fool. Novo Nordisk (NYSE: NVO) Q1 2024 Earnings Call May 02, 2024 , 7:00 a.m. ET Operator Continue reading For further details see: Novo Nordisk (NVO) Q1 2024 Earnings Call Transcript
2024-05-02 12:21:14 ET Novo Nordisk A/S (NVO) Q1 2024 Earnings Conference Call May 2, 2024 07:00 a.m. ET Company Participants Lars Fruergaard Jørgensen - Chief Executive Officer Camilla Sylvest - Executive Vice President, Head of Commercial Strategy & Corpor...
2024-05-02 10:18:21 ET The biotech sector includes companies that utilize biological processes to develop technologies and products for a wide range of industries. This includes healthcare, agriculture, and environmental management. These companies often focus on innovative therapies, medic...
2024-05-02 09:58:32 ET More on Eli Lilly, Novo Nordisk, etc. Eli Lilly Shoots Higher: It's Time To Be Cautious Eli Lilly: The GLP-1 Wonder Continues, A Bullish Beat And Raise Eli Lilly: Management Raises 2024 Guidance, Driven By GLP-1 Franchise Novo Nordisk s...
2024-05-02 09:17:44 ET More on Novo Nordisk Novo Nordisk: Medicare Coverage To Unlock Another Big Market For Wegovy Novo Nordisk Remains The Better Buy After A Moderate Pullback Novo Nordisk: The Moat Won't Last Forever Novo Nordisk lifts guidance as Ozempic,...
2024-05-02 09:11:00 ET U.S. stock index futures on Thursday pointed to a higher open, a day after the Federal Reserve and chair Jerome Powell were widely perceived to be much more dovish than expected. Here are some stocks to watch on Thursday: ... Read the full article on Se...
Resideo Technologies Inc. (REZI) is expected to report $0.33 for Q1 2024 Schneider National Inc. (SNDR) is expected to report $0.13 for Q1 2024 Murphy Oil Corporation (MUR) is expected to report $0.82 for Q1 2024 Astronics Corp. - Class B (ATROB) is expected to report for Q1 2024 ...
2024-05-02 04:11:57 ET More on Novo Nordisk Novo Nordisk: Medicare Coverage To Unlock Another Big Market For Wegovy Novo Nordisk Remains The Better Buy After A Moderate Pullback Novo Nordisk: The Moat Won't Last Forever Novo Nordisk reports Q1 results; update...
2024-05-02 01:40:07 ET More on Novo Nordisk: Novo Nordisk: Medicare Coverage To Unlock Another Big Market For Wegovy Novo Nordisk Remains The Better Buy After A Moderate Pullback Novo Nordisk: The Moat Won't Last Forever Novo, Teva, AstraZeneca issued FTC war...
2024-05-01 17:07:44 ET Summary Amgen Inc. shares have dropped some 20% since reaching an all-time high in February due to a below-consensus outlook and patent concerns. The company's four pillars of growth are General Medicine, Oncology, Inflammatory Diseases, and Rare Diseases. ...
News, Short Squeeze, Breakout and More Instantly...
Novo Nordisk A/S Company Name:
NVO Stock Symbol:
NYSE Market:
2024-05-18 02:35:00 ET Danish pharmaceutical company Novo Nordisk (NYSE: NVO) has established itself as one of the top healthcare stocks in the world with a market cap hovering around $600 billion. Long-term investors earned fantastic returns; in just five years, the share prices of...
The obesity market has garnered much interest lately, ever since Novo Nordisk (NYSE: NVO) received FDA approval for its obesity drug Wegovy in 2021...
Some 42% of adults in the United States are affected by obesity, according to the U.S. CDC. At a global level, a new study released by the journal ...